Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Reelin signaling antagonizes beta-amyloid at the synapse.

Durakoglugil MS, Chen Y, White CL, Kavalali ET, Herz J.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15938-43. doi: 10.1073/pnas.0908176106. Epub 2009 Sep 2.

2.

Factors associated with resistance to dementia despite high Alzheimer disease pathology.

Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M, Montine T, Kaye J.

Neurology. 2009 Jan 27;72(4):354-60. doi: 10.1212/01.wnl.0000341273.18141.64.

3.

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM.

J Neurosci. 2008 Nov 5;28(45):11500-10. doi: 10.1523/JNEUROSCI.3203-08.2008.

4.

The RELN locus in Alzheimer's disease.

Seripa D, Matera MG, Franceschi M, Daniele A, Bizzarro A, Rinaldi M, Panza F, Fazio VM, Gravina C, D'Onofrio G, Solfrizzi V, Masullo C, Pilotto A.

J Alzheimers Dis. 2008 Jul;14(3):335-44.

PMID:
18599960
5.

Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.

Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J, Pe'er I, Burtt NP, Blumenstiel B, DeFelice M, Parkin M, Barry R, Winslow W, Healy C, Graham RR, Neale BM, Izmailova E, Roubenoff R, Parker AN, Glass R, Karlson EW, Maher N, Hafler DA, Lee DM, Seldin MF, Remmers EF, Lee AT, Padyukov L, Alfredsson L, Coblyn J, Weinblatt ME, Gabriel SB, Purcell S, Klareskog L, Gregersen PK, Shadick NA, Daly MJ, Altshuler D.

Nat Genet. 2007 Dec;39(12):1477-82. Epub 2007 Nov 4.

6.

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC.

Am J Hum Genet. 2007 Sep;81(3):559-75. Epub 2007 Jul 25.

7.

Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.

Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L.

J Neurosci. 2007 Mar 14;27(11):2727-33.

8.

Reelin mouse mutants as models of cortical development disorders.

D'Arcangelo G.

Epilepsy Behav. 2006 Feb;8(1):81-90. Epub 2005 Nov 2. Review.

PMID:
16266828
9.
10.

Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.

Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A.

Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12578-83. Epub 2005 Aug 19.

11.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419
12.

Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA.

Arch Neurol. 2003 Aug;60(8):1119-22.

PMID:
12925369
13.

Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade.

Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J, Maeda N, Vitek MP, Mitsuda N.

FASEB J. 2003 Feb;17(2):295-7. Epub 2002 Dec 18.

PMID:
12490540
14.
15.

Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Wirths O, Multhaup G, Czech C, Blanchard V, Tremp G, Pradier L, Beyreuther K, Bayer TA.

Neurosci Lett. 2001 Dec 28;316(3):145-8.

PMID:
11744223
16.
17.

Histone acetylation and disease.

Timmermann S, Lehrmann H, Polesskaya A, Harel-Bellan A.

Cell Mol Life Sci. 2001 May;58(5-6):728-36. Review.

PMID:
11437234
18.

The evolution of cortical development. An hypothesis based on the role of the Reelin signaling pathway.

Bar I, Lambert de Rouvroit C, Goffinet AM.

Trends Neurosci. 2000 Dec;23(12):633-8. Review.

PMID:
11137154
19.

APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.

Juva K, Verkkoniemi A, Viramo P, Polvikoski T, Kainulainen K, Kontula K, Sulkava R.

Neurology. 2000 Jan 25;54(2):412-5.

PMID:
10668704
20.

Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation.

Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J.

Neuron. 1999 Oct;24(2):481-9.

Supplemental Content

Support Center